Asia Pacific Cardiovascular Needle Market to Grow at a CAGR of 7.8% to reach US$ 31,968.6 thousands by 2028 Million from 2021 to 2028

Asia Pacific Cardiovascular Needle Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Round-Bodied Needles, and Cutting Needles); Application (Open Heart Surgery, and Cardiac Valve Procedures); Usage (Single Use, and Multiple Uses); End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Cardiovascular Centers)

  • Report Code : TIPRE00025897
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 122
Buy Now

The cardiovascular needle market in Asia Pacific is expected to grow from US$ 18.80 Million in 2021 to US$ 31.96 Million by 2028; it is estimated to grow at a CAGR of 7.8% from 2021 to 2028

.

Cardiovascular diseases (CVDs) are the disorders of heart and blood vessels, and the category includes cerebrovascular disease, coronary heart disease, rheumatic heart disease, and other conditions. Tobacco consumption, unhealthy diet, and physical inactivity, which increase the risk of heart attacks and strokes, are a few of the major lifestyle factors that lead to the CVDs. Other risk factors causing these diseases include hypertension, diabetes, and increased cholesterol levels. CVDs are among the top 10 causes of death. According to the World Health Organization (WHO), cardiovascular diseases are number one cause of the death. Cardiovascular diseases (CVDs) are likely to remain the largest cause of morbidity and mortality. Fat depositions around blood vessels that prevents blood from flowing to the heart or brain is a main cause of heart attack and stroke. Bleeding vessels or blood clots in brain are a few other causes of stroke. Thus, the significantly rising incidence of CVDs is contributing to the high demand for diagnostic and treatment cardiovascular devices, which is driving the cardiovascular needle market growth.

The outbreak has severely affected the medical tourism industry in Asia pacific and imposed supply chain disruptions; moreover, low-income countries face additional challenges due to the shortage of healthcare infrastructure, restrictions imposed by hospitals to the suppliers, decreasing in demand of cardiovascular surgical instruments and others. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent the disease transmission. These restrictive measures are anticipated to impact the supply chain and the availability of medical devices in these countries. It has affected disposable incomes and has also resulted in unemployment. Furthermore, business strategies such as acquisitions, mergers, and partnerships are adversely affected by the imposition of complete lockdown. Such obstructions in business activities are projected to hamper the manufacturing and distribution of several cardiovascular surgical instruments. However, increasing vaccination across the region and availability of government reimbursement policies for various cardiovascular procedures is expected to normalize the situation in Asia Pacific region and will gradually increase the demand for cardiovascular needles.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the cardiovascular needle market. The Asia Pacific cardiovascular needle market is expected to grow at a good CAGR during the forecast period.

Asia Pacific cardiovascular needle market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Asia Pacific Cardiovascular Needle Market Segmentation          

By Application

  • Open Heart Surgery
  • Cardiac Valve Procedures

By Usage

  • Single Use
  • Multiple Uses

By End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centres
  • Cardiovascular Centres

By Country

  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific

Companies Mentioned

  1. Ethicon (Johnson & Johnson Services, Inc.)    
  2. MANI, INC         
  3. Barber of Sheffield       
  4. FSSB surgical needles GmbH    
  5. Medtronic         
  6. Teleflex Incorporated    
  7. Meril Life Sciences Pvt. Ltd.      
  8. CP Medical        
  9. SMB Corporation of India
  10. Aurolab
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Cardiovascular Needle Market – By Type

1.3.2 Cardiovascular Needle Market – By Application

1.3.3 Cardiovascular Needle Market – By Usage

1.3.4 Cardiovascular Needle Market – By End User

1.3.5 Asia Pacific Cardiovascular Needle Market – By Country

2. Asia Pacific Cardiovascular Needle Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Cardiovascular Needle Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Cardiovascular Needle Market- Asia Pacific PEST Analysis

4.3 Expert Opinion

5. Asia Pacific Cardiovascular Needle Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Cardiovascular Diseases

5.1.2 Rise in Elderly Population

5.2 Key Market Restraints

5.2.1 Preference for Surgical Staples over Needles

5.3 Key Market Opportunities

5.3.1 Growth Opportunities in Developing Nations

5.4 Future Trends

5.4.1 Proliferation of MedTech Industry

5.5 Impact Analysis

6. Cardiovascular Needle Market – Asia Pacific Analysis

6.1 Asia Pacific Cardiovascular Needle Market Revenue Forecasts and Analysis

7. Asia Pacific Cardiovascular Needle Market Analysis and Forecasts To 2028 – By Type

7.1 Overview

7.2 Cardiovascular Needle Market Revenue Share, by Type (2020 and 2028)

7.3 Round-Bodied Needles

7.3.1 Overview

7.3.2 Round-Bodied Needles: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

7.4 Cutting Needles

7.4.1 Overview

7.4.2 Cutting Needles: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

8. Asia Pacific Cardiovascular Needle Market Analysis and Forecasts To 2028 – By Application

8.1 Overview

8.2 Cardiovascular Needle Market Revenue Share, by Application (2020 and 2028)

8.3 Open Heart Surgery

8.3.1 Overview

8.3.2 Open Heart Surgery: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

8.4 Cardiac Valve Procedures

8.4.1 Overview

8.4.2 Cardiac Valve Procedures: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

9. Asia Pacific Cardiovascular Needle Market Analysis and Forecasts To 2028 – By Usage

9.1 Overview

9.2 Cardiovascular Needle Market Revenue Share, by Usage (2020 and 2028)

9.3 Single Use

9.3.1 Overview

9.3.2 Single Use: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

9.4 Multiple Use

9.4.1 Overview

9.4.2 Multiple Use: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

10. Asia Pacific Cardiovascular Needle Market Analysis and Forecasts To 2028 –By End user

10.1 Overview

10.2 Cardiovascular Needle Market Revenue Share, by End User (2020 and 2028)

10.3 Hospitals and Clinics

10.3.1 Overview

10.3.2 Hospitals and Clinics: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

10.4 Ambulatory Surgical Centers

10.4.1 Overview

10.4.2 Ambulatory Surgical Centers: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

10.5 Cardiovascular Centers

10.5.1 Overview

10.5.2 Cardiovascular Centers: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

11. Cardiovascular Needle Market Revenue and Forecasts to 2028 – Geographical Analysis

11.1 Asia Pacific: Cardiovascular Needle Market

11.1.1 Overview

11.1.2 Asia Pacific: Cardiovascular Needle Market, by Country, 2021 & 2028 (%)

11.1.2.1 China: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

11.1.2.1.1 China: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

11.1.2.1.2 China: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)

11.1.2.1.3 China: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)

11.1.2.1.4 China: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)

11.1.2.1.5 China: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)

11.1.2.2 Japan: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

11.1.2.2.1 Japan: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

11.1.2.2.2 Japan: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)

11.1.2.2.3 Japan: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)

11.1.2.2.4 Japan: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)

11.1.2.2.5 Japan: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)

11.1.2.3 India: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

11.1.2.3.1 India: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

11.1.2.3.2 India: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)

11.1.2.3.3 India: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)

11.1.2.3.4 India: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)

11.1.2.3.5 India: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)

11.1.2.4 Australia: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

11.1.2.4.1 Australia: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

11.1.2.4.2 Australia: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)

11.1.2.4.3 Australia: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)

11.1.2.4.4 Australia: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)

11.1.2.4.5 Australia: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)

11.1.2.5 South Korea: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

11.1.2.5.1 South Korea: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

11.1.2.5.2 South Korea: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)

11.1.2.5.3 South Korea: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)

11.1.2.5.4 South Korea: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)

11.1.2.5.5 South Korea: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)

11.1.2.6 Rest of Asia Pacific: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

11.1.2.6.1 Rest of Asia Pacific: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

11.1.2.6.2 Rest of Asia Pacific: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)

11.1.2.6.3 Rest of Asia Pacific: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)

11.1.2.6.4 Rest of Asia Pacific: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)

11.1.2.6.5 Rest of Asia Pacific: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)

12. Impact Of COVID-19 Pandemic on Asia Pacific Cardiovascular Needle Market

12.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

13. Industry Landscape

13.1 Overview

14. Company Profiles

14.1 Ethicon (Johnson & Johnson Services, Inc.)

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 MANI,INC

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Barber of Sheffield

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 FSSB surgical needles GmbH

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Medtronic

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Teleflex Incorporated

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Meril Life Sciences Pvt. Ltd.

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 CP Medical

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 SMB Corporation of India

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Aurolab

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About the Insight Partners

15.2 Glossary of Terms


LIST OF TABLES

Table 1. China: Cardiovascular Needle Market, By Type – Revenue and Forecast to 2028 (USD Thousands)

Table 2. China: Cardiovascular Needle Market, by Application – Revenue and Forecast to 2028 (USD Thousands)

Table 3. China: Cardiovascular Needle Market, by Usage– Revenue and Forecast to 2028 (USD Thousands)

Table 4. China: Cardiovascular Needle Market, by End User– Revenue and Forecast to 2028 (USD Thousands)

Table 5. Japan: Cardiovascular Needle Market, By Type– Revenue and Forecast to 2028 (USD Thousands)

Table 6. Japan: Cardiovascular Needle Market, by Application– Revenue and Forecast to 2028 (USD Thousands)

Table 7. Japan: Cardiovascular Needle Market, by Usage – Revenue and Forecast to 2028 (USD Thousands)

Table 8. Japan: Cardiovascular Needle Market, by End User – Revenue and Forecast to 2028 (USD Thousands)

Table 9. India: Cardiovascular Needle Market, By Type– Revenue and Forecast to 2028 (USD Thousands)

Table 10. India: Cardiovascular Needle Market, by Application – Revenue and Forecast to 2028 (USD Thousands)

Table 11. India: Cardiovascular Needle Market, by Usage– Revenue and Forecast to 2028 (USD Thousands)

Table 12. India: Cardiovascular Needle Market, by End User– Revenue and Forecast to 2028 (USD Thousands)

Table 13. Australia: Cardiovascular Needle Market, By Type – Revenue and Forecast to 2028 (USD Thousands)

Table 14. Australia: Cardiovascular Needle Market, by Application– Revenue and Forecast to 2028 (USD Thousands)

Table 15. Australia: Cardiovascular Needle Market, by Usage– Revenue and Forecast to 2028 (USD Thousands)

Table 16. Australia: Cardiovascular Needle Market, by End User– Revenue and Forecast to 2028 (USD Thousands)

Table 17. South Korea: Cardiovascular Needle Market, By Type – Revenue and Forecast to 2028 (USD Thousands)

Table 18. South Korea: Cardiovascular Needle Market, by Application – Revenue and Forecast to 2028 (USD Thousands)

Table 19. South Korea: Cardiovascular Needle Market, by Usage– Revenue and Forecast to 2028 (USD Thousands)

Table 20. South Korea: Cardiovascular Needle Market, by End User– Revenue and Forecast to 2028 (USD Thousands)

Table 21. Rest of Asia Pacific: Cardiovascular Needle Market, By Type – Revenue and Forecast to 2028 (USD Thousands)

Table 22. Rest of Asia Pacific: Cardiovascular Needle Market, by Application – Revenue and Forecast to 2028 (USD Thousands)

Table 23. Rest of Asia Pacific: Cardiovascular Needle Market, by Usage– Revenue and Forecast to 2028 (USD Thousands)

Table 24. Rest of Asia Pacific: Cardiovascular Needle Market, by End User– Revenue and Forecast to 2028 (USD Thousands)

Table 25. Glossary of Terms, Cardiovascular Needle Market


LIST OF FIGURES

Figure 1. Cardiovascular Needle Market Segmentation

Figure 2. Asia Pacific Cardiovascular Needle Market Overview

Figure 3. Round-Bodied Needles Segment Held Largest Share of Type in Cardiovascular Needle Market

Figure 4. Japan is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. Cardiovascular Needle Market - Asia Pacific PEST Analysis

Figure 6. Cardiovascular Needle Market Impact Analysis of Driver and Restraints

Figure 7. Asia Pacific Cardiovascular Needle Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8. Cardiovascular Needle Market Revenue Share, by Type (2020 and 2028)

Figure 9. Round-Bodied Needles: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 10. Cutting Needles: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 11. Cardiovascular Needle Market Revenue Share, by Application (2020 and 2028)

Figure 12. Open Heart Surgery: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 13. Cardiac Valve Procedures: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 14. Cardiovascular Needle Market Revenue Share, by Usage (2020 and 2028)

Figure 15. Single Use: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 16. Multiple Use: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 17. Cardiovascular Needle Market Revenue Share, by End User (2020 and 2028)

Figure 18. Hospitals and Clinics: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 19. Ambulatory Surgical Centers: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 20. Cardiovascular Centers: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 21. Asia Pacific: Cardiovascular Needle Market, by Key Country – Revenue (2021) (USD Thousands)

Figure 22. Asia Pacific: Cardiovascular Needle Market, by Country, 2021 & 2028 (%)

Figure 23. China: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

Figure 24. Japan: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

Figure 25. India: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

Figure 26. Australia: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

Figure 27. South Korea: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

Figure 28. Rest of Asia Pacific: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)

Figure 29. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

  1. Ethicon (Johnson & Johnson Services, Inc.)              
  2. MANI, INC              
  3. Barber of Sheffield             
  4. FSSB surgical needles GmbH          
  5. Medtronic              
  6. Teleflex Incorporated       
  7. Meril Life Sciences Pvt. Ltd.             
  8. CP Medical             
  9. SMB Corporation of India
  10. Aurolab

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Asia Pacific Cardiovascular Needle Market